Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer

오도연 Toshihiko Doi Kuniaki Shirao 이근욱 박숙련 Ying Chen Liqiang Yang Olga Valota 방영주 2015년

연구자정보

공동연구/유사연구

논문점유율 요약
동일주제 총논문수	주제별 연구자 총논문수	연구자점유율(주제별 연구자점유율의 평균)
2,599	45	22.4%

연구자 점유율
주제		주제별 논문수	주제별 연구자논문수	주제별 연구자점유율
주제분류(KDC/DDC)	내과학	1,284	7	0.5%
주제어	opb-31121	1	1	100.0%
	rna stability	1	1	100.0%
	stat3 inhibitor	1	1	100.0%
	tristetraprolin	1	1	100.0%
	mediastinallymphnode	2	1	50.0%
	phase1	2	1	50.0%
	adjuvant chemoradiotherapy	3	1	33.3%
	axitinib	3	1	33.3%
	pulmonarynodule	3	1	33.3%
	solid tumor	3	1	33.3%
	phase i	7	2	28.6%
	cyclooxygenase2	4	1	25.0%
	smad3	5	1	20.0%
	splenic artery	6	1	16.7%
	p-glycoprotein	10	1	10.0%
	benign	11	1	9.1%
	capecitabine	14	1	7.1%
	gallbladder neoplasms	15	1	6.7%
	transforming growth factor be ...	17	1	5.9%
	gemcitabine	18	1	5.6%
	cisplatin	46	2	4.3%
	pancreatectomy	26	1	3.8%
	biliarytractneoplasms	30	1	3.3%
	oral	35	1	2.9%
	pharmacokinetics	80	2	2.5%
	clinical trial	82	2	2.4%
	cholangiocarcinoma	43	1	2.3%
	administration	51	1	2.0%
	paclitaxel	80	1	1.3%
	stat3	86	1	1.2%
	breast neoplasms	104	1	1.0%
	pancreatic neoplasms	103	1	1.0%
	neoplasm metastasis	111	1	0.9%
	stomach neoplasms	311	1	0.3%
계		2,599	45
* 주제로 분류 되지 않은 논문건수			0